Nonmotor-Related Quality of Life in Parkinson’s Patients with Subjective Memory Complaints: Comparison with PDQ-39
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
The three-model screen
all 1,000 screened works →All three models called this out of scope.
Study of quality of life and memory complaints in Parkinson's patients; the call for validated tools is a clinical instrument note, not metaresearch.
This studies quality of life and memory complaints in Parkinson’s patients, not research itself.
Clinical study linking Parkinson's subjective memory complaints to quality of life; patient outcomes, not research practice.
Abstract
BACKGROUND: Parkinson's disease (PD) is associated with cognitive decline, progressing from subjective memory complaints (SMC) via mild cognitive impairment (MCI) to dementia. SMC are only measurable by an interview and thus rely on individuals reporting a subjectively perceived worsening of cognitive functioning. Cognitive decline is accompanied by a reduction in quality of life (QoL); however, the extent to which SMC manifest a reduction of QoL remains unclear. OBJECTIVE: To determine the association between SMC and deterioration of QoL in patients suffering from PD. METHODS: A total of 46 cognitively unimpaired PD patients (29 men and 17 women) completed PDQ-39, two assessments to measure SMC (Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and a Self-Assessment questionnaire), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI). Multiple regression modelling was conducted to investigate the confounding effect of depression and anxiety. RESULTS: = 0.55). CONCLUSION: In our study, SMC is significantly related to a reduction of cognitive QoL. In addition, we observed significant relation to anxiety and depression levels. In contrast to our main hypothesis, we found no association with overall QoL; this lack of association could be due to unstandardized questionnaires and emphasizes the need of validated tools for evaluating SMC.
Stored with the screening record, where it is evidence for the labels above.
The record
- Venue
- Parkinson s Disease
- Topic
- Parkinson's Disease Mechanisms and Treatments
- Field
- Medicine
- Canadian institutions
- —
- Funders
- Parkinson SchweizFondation BotnarNational Science Foundation, United Arab EmiratesNational Research FoundationMach-Gaensslen Foundation of Canada
- Keywords
- MedicineParkinson's diseaseQuality of life (healthcare)GerontologyPhysical medicine and rehabilitationInternal medicineDiseaseNursing
- Has abstract in OpenAlex
- yes